$ETTX Entasis Therapeutics Holdings Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Entasis Therapeutics Holdings Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Entasis Therapeutics Holdings Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Entasis Therapeutics Holdings Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Altarac David | Chief Medical Officer | 25,000 | 0 | Jan 19 2021 | |||
| ASTRAZENECA PLC | 10% Owner | 1,918,189 | 0 | Oct 02 2018 | |||
| Behanna Heather | Director | 22,000 | 0 | Apr 02 2021 | |||
| Clarus Lifesciences III, L.P. | 10% Owner | 361,829 | 0 | Oct 02 2018 | |||
| Frazier Life Sciences VIII, L.P. | 10% Owner | 1,299,953 | 0 | Jan 13 2020 | |||
| GALAKATOS NICHOLAS | Director | 361,829 | 0 | Jun 21 2019 | |||
| Gutch Michael | Chief Fin. and Bus. Officer | 0 | 0 | Jan 27 2020 | |||
| HASTINGS DAVID C | Director | 22,000 | 0 | Apr 02 2021 | |||
| Isaacs Robin | Chief Medical Officer | 0 | 0 | Jan 22 2019 | |||
| Keiley Elizabeth M | General Counsel | 25,000 | 0 | Jan 19 2021 | |||
| Kimble Eric Wilson | Chief Commercial Officer | 0 | 0 | Jan 27 2020 | |||
| Mayer Howard | Director | 22,000 | 0 | Apr 02 2021 | |||
| Meek David D. | Director | 22,000 | 0 | Apr 02 2021 | |||
| Mueller John Patrick | Chief Development Officer | 25,000 | 0 | Jan 19 2021 | |||
| Norden Gregory | Director | 0 | 0 | Jun 21 2019 | |||
| Novo A/S | 10% Owner | 1,092,008 | 0 | Oct 01 2018 | |||
| Perros Manoussos | President & CEO | 79,750 | 0 | Jan 19 2021 | |||
| Pivotal bioVenture Partners Fund I, L.P. | 10% Owner | 359,267 | 0 | Oct 02 2018 | |||
| Preston Heather | Director | 359,267 | 0 | Jun 21 2019 | |||
| Ronsheim Matthew | See Remarks | 25,000 | 0 | Jan 19 2021 | |||
| Sofinnova Venture Partners IX, L.P. | 10% Owner | 359,267 | 0 | Oct 02 2018 | |||
| THERAVANCE INC | 10% Owner | 18,672,897 | 0 | Sep 01 2020 | |||
| Tommasi Rubin | Chief Scientific Officer | 47,024 | 0 | Jan 19 2021 | |||
| Topper James N | Director | 337,707 | 0 | Jan 22 2019 | |||
| TPG Group Holdings (SBS) Advisors, Inc. | 735,924 | 0 | Oct 02 2018 |